EC

Edouard Caram

Sr Director Global Partnering Neurosciences & Rare Diseases

Paris, Île-de-France

Invests in

Stages:

Locations:

  • Min Investment:

    $100,000.00
  • Max Investment:

    $5,000,000.00
  • Target Investment:

    $1,500,000.00

Work Experience

2022

  • Sr Director Global Partnering Neurosciences & Rare Diseases

    2022

  • Business Angel

    2020

  • Board Member

    2021

    Open Stent Solution (OSS) develops the first longitudinally expandable valved stent, paving the way for the new open stent concept for the treatment of heart valve disease.

2021 - 2022

  • Board Member

    2021 - 2022

2020 - 2022

  • Blog founder

    2020 - 2022

    In VCLife topics dealing with early sciences, funding, entrepreneurs, Big Pharmas, M&A, patients care will be openly debate. There will be an important footprint on Therapeutics but Med Tech, Diagnostic and the revolution of Digital Health will also feed the posts. Discussion and feed back are always welcome thus do not hesitate to comment or email me.

2015 - 2022

  • FONDATEUR ET DIRIGEANT

    2015 - 2022

    CLOSINVIT est une plateforme unique d'invitations pour des spectacles vivants. Cinéma, théâtre, spectacles humoristiques, nouvelles comédies, nouvelles production à découvrir. CLOSINVIT: INVITEZ-VOUS ! www.closinvit.com

2011 - 2022

  • Fondateur et dirigeant

    2011 - 2022

    Billetterie en ligne et promotion de spectacles vivants avec près de 60'000 membres. Rejoignez Closevent sur: http://www.closevent.com/mon_compte-10.html

2007 - 2010

  • Investment Analyst Life Science

    2007 - 2010

    Evaluation of early stage/ spin off investments in Life Science (Biopharma and device companies). Sourcing, diligence of > 400 opportunities and completion of 2 US deals.

2006 - 2007

  • Manager Marketing & Corporate Development Europe

    2006 - 2007

    In charge of the Marketing strategy and activities of the company portfolio in Europe (Monoclonal Antibodies in Inflammation, Solid tumor, multiple myeloma)

  • Manager Business Development (Licence & acquisition)

    2002 - 2006

    Co-leading EU licensing/ acquisition projects in METABOLISM (diabetes/ obesity) and VIROLOGY (HIV, HBV, HCV, vaccines).